Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection.
暂无分享,去创建一个
M. Peluso | D. Fuchs | H. Zetterberg | D. Meyerhoff | R. Price | B. Brew | K. Robertson | L. Hagberg | P. Cinque | M. Gisslén | S Spudich | Julia Peterson | Evelyn Lee | A. C. Young | Rudy Walter
[1] K. Blennow,et al. Open‐heart surgery increases cerebrospinal fluid levels of Alzheimer‐associated amyloid β , 2013, Acta anaesthesiologica Scandinavica.
[2] D. Meyerhoff,et al. Glutamate, GABA, and other cortical metabolite concentrations during early abstinence from alcohol and their associations with neurocognitive changes. , 2012, Drug and alcohol dependence.
[3] Jintanat Ananworanich,et al. Central nervous system viral invasion and inflammation during acute HIV infection. , 2012, The Journal of infectious diseases.
[4] D. Fuchs,et al. Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden. , 2011, The Journal of infectious diseases.
[5] E. Halpern,et al. Brain creatine elevation and N‐acetylaspartate reduction indicates neuronal dysfunction in the setting of enhanced glial energy metabolism in a macaque model of NeuroAIDS , 2011, Magnetic resonance in medicine.
[6] J. Morris,et al. Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease , 2010, Science.
[7] Terry L. Jernigan,et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors , 2010, Journal of NeuroVirology.
[8] Linda Chang,et al. Lower brain glutamate is associated with cognitive deficits in HIV patients: A new mechanism for HIV‐associated neurocognitive disorder , 2010, Journal of magnetic resonance imaging : JMRI.
[9] M. Weiner,et al. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease , 2010, Nature Reviews Neurology.
[10] K. Blennow,et al. Amyloid and tau cerebrospinal fluid biomarkers in HIV infection , 2009, BMC neurology.
[11] A. Fagan,et al. CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease , 2009, Neurology.
[12] E. Halpern,et al. In vivo proton magnetic resonance spectroscopy reveals region specific metabolic responses to SIV infection in the macaque brain , 2009, BMC Neuroscience.
[13] J T Becker,et al. Biomarkers of HIV-1 CNS infection and injury , 2007, Neurology.
[14] R. Price,et al. Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection , 2007, Neurology.
[15] R. Price,et al. Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex. , 2007, The Journal of infectious diseases.
[16] R. Price,et al. CSF neurofilament protein (NFL) — a marker of active HIV-related neurodegeneration , 2007, Journal of Neurology.
[17] I. Grant,et al. The impact of neuropsychological functioning and depressed mood on functional complaints in HIV-1 infection and methamphetamine dependence , 2007, Journal of clinical and experimental neuropsychology.
[18] C. Pilcher,et al. Diagnosis and management of acute HIV infection. , 2007, Infectious disease clinics of North America.
[19] K. Blennow,et al. Neurochemical aftermath of amateur boxing , 2006, Archives of neurology.
[20] R. Gonzalez,et al. New Insights into the Neuroimmunity of SIV Infection by Magnetic Resonance Spectroscopy , 2006, Journal of Neuroimmune Pharmacology.
[21] K. Blennow,et al. CSF amyloid β42 and tau levels correlate with AIDS dementia complex , 2005, Neurology.
[22] C. Petropoulos,et al. Cerebrospinal fluid HIV infection and pleocytosis: Relation to systemic infection and antiretroviral treatment , 2005, BMC infectious diseases.
[23] R. Price,et al. Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection , 2005, AIDS research and therapy.
[24] E. Halpern,et al. Quantitative neuropathologic correlates of changes in ratio of N-acetylaspartate to creatine in macaque brain. , 2005, Radiology.
[25] Hilkka Soininen,et al. CSF Aβ42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment , 2005, Neurology.
[26] E. Masliah,et al. Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients , 2005, AIDS.
[27] N. Norgren,et al. Neurofilament and glial fibrillary acidic protein in multiple sclerosis , 2004, Neurology.
[28] Linda Chang,et al. Regional patterns of brain metabolites in AIDS dementia complex , 2004, NeuroImage.
[29] N. Norgren,et al. Elevated neurofilament levels in neurological diseases , 2003, Brain Research.
[30] H. Vanderstichele,et al. Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt–Jakob disease from other dementias , 2003, Molecular Psychiatry.
[31] W. Miller,et al. HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health , 2001, AIDS.
[32] K. Blennow,et al. Both total and phosphorylated tau are increased in Alzheimer's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.
[33] M. Grassi,et al. Beta amyloid precursor protein and patterns of HIV p24 immunohistochemistry in different brain areas of AIDS patients , 2001, AIDS.
[34] V. Calvez,et al. Clinical and spectroscopic improvement in HIV-associated cognitive impairment , 2001, Neurology.
[35] L. Papagno,et al. Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[36] D. Fuchs,et al. Intrathecal immune activation is associated with cerebrospinal fluid markers of neuronal destruction in AIDS patients , 2000, Journal of Neuroimmunology.
[37] K. Blennow,et al. Increased cerebrospinal fluid protein tau concentration in neuro-AIDS , 1999, Journal of the Neurological Sciences.
[38] V. Govindaraju,et al. Automated spectral analysis III: Application to in Vivo proton MR Spectroscopy and spectroscopic imaging , 1998, Magnetic resonance in medicine.
[39] D. Galasko,et al. Cerebrospinal fluid tau protein is not elevated in HIV-associated neurologic disease in humans , 1998, Neuroscience Letters.
[40] T. Schacker,et al. Clinical and Epidemiologic Features of Primary HIV Infection , 1996, Annals of Internal Medicine.
[41] Michael J. Taylor,et al. The HNRC 500-Neuropsychology of Hiv infection at different disease stages , 1995, Journal of the International Neuropsychological Society.
[42] G. Fein,et al. Reduced brain N‐acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus‐seropositive individuals , 1993, Neurology.
[43] K. Blennow,et al. CSF amyloid beta42 and tau levels correlate with AIDS dementia complex. , 2005, Neurology.
[44] H. Soininen,et al. CSF Abeta42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment. , 2005, Neurology.